Rob Koremans
"Rob Koremans joined Nutreco as per 1 October 2018. Rob is a Doctor of Medicine from RSM Erasmus University in the Netherlands. Over the past 30 years, he has held different managerial and executive roles, mainly in the pharmaceutical industry including Serono, Grünenthal and Sanofi-Aventis in The Netherlands, Germany, Czech Republic and Switzerland. He was most recently President and CEO Global Specialty Medicines and a member of the Executive Committee at Teva Pharmaceutical Industries Ltd."[1]
"Global Specialty Medicines was founded in 2013 as a subsidiary of Teva Pharmaceutical Industries, a maker of generic and proprietary drugs. In addition to his leadership at Global Specialty Medicines, Koremans is also a member of Teva Pharmaceuticals’ executive committee.
"From 2012 to 2013, Koremans served as president and CEO of Teva Pharmaceuticals Europe. From 2009 to 2012, Koremans was a member of the executive team at biopharmaceutical company Sanofi. Prior to that role, he served as senior vice president generics, strategy, and development at Sanofi. He also worked as CEO of Zentiva and Cryo-Save, and worked in senior positions at Grunenthal GmbH and Serono. " [1]
Resources and articles
Related Sourcewatch
References
- ↑ Nutreco Executive Committee, organizational web page, accessed October 8, 2018.
